Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Birte Yding Glenthøj

'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response

scientific article published on 28 August 2017

17.2 NEGATIVE SYMPTOMS IN THE OPTiMISE COHORT: PREDICTION OF SHORT-TERM REMISSION STATE AND ASSOCIATION WITH PSYCHOSOCIAL FUNCTIONING

article by Armida Mucci et al published 9 April 2019 in Schizophrenia Bulletin

17.3 USING RASCH ANALYSIS TO IDENTIFY NEGATIVE SYMPTOM RESPONSE TRAJECTORIES IN FIRST-EPISODE SCHIZOPHRENIA

17.4 STRATIFICATION AND PREDICTION OF REMISSION IN FIRST-EPISODE PSYCHOSIS PATIENTS: THE OPTiMISE COHORT STUDY

article by Nicolas Glaichenhaus et al published 9 April 2019 in Schizophrenia Bulletin

31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS.

scientific article published in April 2018

48. Associations Between Electrophysiological Measures of Selective Attention and Neurocognitive Measures of Working Memory and Attention in Antipsychotic-Naive, First-Episode Schizophrenia Patients.

scientific article published on 20 March 2017

84. Neurometabolite Heritability and Correlation With Schizophrenia in Anterior Cingulate and Left Thalamus: An MRS Twin Study.

scientific article published on 20 March 2017

87. Glutamate and GABA in Antipsychotic-Naive Schizophrenia and Association With Treatment Outcome.

scientific article

A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes

scientific article

A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale

scientific article published on 27 June 2019

A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data

scientific article published on 10 August 2020

A mixed modality paradigm for recording somatosensory and auditory P50 gating

scientific article published in December 2001

A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention.

scientific article published on 19 June 2006

A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging

scientific article published on 2 May 2013

A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers

scientific article published on 23 October 2010

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers.

scientific article published on 20 March 2009

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients

scientific article published on 18 December 2018

Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports

scientific article published on 4 November 2014

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia.

scientific article published on 19 January 2018

Alterations of the brain reward system in antipsychotic naïve schizophrenia patients

scientific article published on 13 March 2012

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

article

Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study

scientific article published on 3 November 2009

Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia--gating of auditory-evoked potentials and prepulse inhibition

scientific article published on 24 April 2010

Association Study of CHRNA7 Promoter Variants with Sensory and Sensorimotor Gating in Schizophrenia Patients and Healthy Controls: A Danish Case-Control Study

scientific article published on 16 September 2015

Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis

scientific article published on 13 November 2019

Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis

scientific article published on 31 March 2011

Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

scientific article published on 19 June 2018

Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study

scientific article published on 20 April 2020

Associations of neural processing of reward with posttraumatic stress disorder and secondary psychotic symptoms in trauma-affected refugees

scientific article published on 04 March 2020

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method

Auditory processing in autism spectrum disorder: Mismatch negativity deficits

scientific article

Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder

scientific article published on 24 October 2019

Auditory sensory processing deficits in sensory gating and mismatch negativity-like responses in the social isolation rat model of schizophrenia

scientific article published on 5 March 2014

BASELINE MEASURES OF CEREBRAL GLUTAMATE AND GABA LEVELS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: IMPLICATIONS FOR CLINICAL OUTCOME AFTER 12 MONTHS

scientific article published on 07 August 2020

Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug

scientific article published on 13 March 2007

Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics

scientific article

Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition

scientific article published on 19 December 2019

Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies

scientific article published on 26 November 2019

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

scientific article

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis

scientific article published on 19 October 2020

Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication

scientific article published on 8 October 2013

Clonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication

scientific article

Clustering of antipsychotic-naïve patients with schizophrenia based on functional connectivity from resting-state electroencephalography

Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia

scientific article

Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophrenia

scientific article published on 13 November 2010

Common variants at VRK2 and TCF4 conferring risk of schizophrenia

scientific article published on 26 July 2011

Comparing Pharmacological Modulation of Sensory Gating in Healthy Humans and Rats: The Effects of Reboxetine and Haloperidol

scientific article published on July 2015

Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia

scientific article published on 4 December 2013

Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study.

scientific article published on 21 June 2019

Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients

scientific article (publication date: 20 February 2008)

Cortical brain dysfunction in early schizophrenia: secondary pathogenetic hierarchy of neuroplasticity, psychopathology and social impairment.

scientific article

Cortical structures and their clinical correlates in antipsychotic-naïve schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment

scientific article published on 08 May 2018

Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia

scientific article (publication date: 2010)

Decreased gene expression of neuropeptide Y and its receptors in hippocampal regions during ethanol withdrawal in rats

scientific article published on 09 August 2007

Deficient prepulse inhibition of the startle reflex in schizophrenia using a cross-modal paradigm

scientific article

Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment

scholarly article by Ann-Marie Low et al published 1 November 2018 in The International Journal of Neuropsychopharmacology

Development of vacuous chewing movements in rats: role of housing environment

scientific article published on 01 January 1991

Diagnostic stability and long-term symptomatic and functional outcomes in first-episode antipsychotic-naïve patients with schizophrenia

scientific article published on 12 October 2019

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years

scientific article published on 11 March 2020

Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens

scientific article

Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention

scientific article published on 31 October 2007

Dopaminergic sensitization of rats with and without early prefrontal lesions: implications for the pathogenesis of schizophrenia

scientific article published on 01 December 1999

Dopaminergic sensitization: implications for the pathogenesis of schizophrenia

scientific article published on January 1997

Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial

scientific article published on 26 September 2016

Effect of a dopamine D-1 agonist in rats treated chronically with zuclopenthixol

scientific article published on 01 January 1990

Effect of an NCAM mimetic peptide FGL on impairment in spatial learning and memory after neonatal phencyclidine treatment in rats

scientific article published on 14 December 2008

Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients

scientific article

Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients

scientific article published in November 2002

Effects of chronic discontinuous and continuous treatment of rats with a dopamine D1 receptor antagonist (NNC-756)

scientific article published on 01 October 1993

Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication

scientific article published on 23 February 2019

Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study

scientific article published on 01 January 2007

Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients

scientific article

Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients

scientific article published in May 2004

Effects of melatonin on prepulse inhibition, habituation and sensitization of the human startle reflex in healthy volunteers.

scientific article published on 28 February 2014

Erratum to: Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.

scientific article published on 5 January 2018

Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients

scientific article published on November 2010

Evaluation of a neurodevelopmental model of schizophrenia--early postnatal PCP treatment in attentional set-shifting.

scientific article published on 20 February 2008

Expanding the range of ZNF804A variants conferring risk of psychosis

scientific article published on 5 January 2010

Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey

scientific article published on 19 October 2010

Extrastriatal dopamine D2/3 receptors and cortical grey matter volumes in antipsychotic-naïve schizophrenia patients before and after initial antipsychotic treatment

scientific article

F125. QUALITY OF LIFE IN DISCORDANT TWIN-PAIRS WITH SCHIZOPHRENIA SPECTRUM DISORDER – RESULTS FROM THE VIP-STUDY

article by Helle Schaebel et al published 9 April 2019 in Schizophrenia Bulletin

F16. GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS ARE ASSOCIATED WITH TREATMENT OUTCOME AFTER 1.5 AND 6 MONTHS.

scientific article published in April 2018

F176. CLINICAL CORRELATES OF CORTICAL STRUCTURE IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BEFORE AND AFTER SIX-WEEK TREATMENT WITH A DOPAMINE D2/3 RECEPTOR ANTAGONIST.

scientific article

F21. ELECTROPHYSIOLOGICAL PARAMETERS OF SELECTIVE ATTENTION IN ADOLESCENTS WITH A FIRST EPISODE OF PSYCHOSIS: A COMPARISON WITH ADHD.

scientific article published in April 2018

F236. CLONIDINE NORMALIZES MMN IN SCHIZOPHRENIA PATIENTS ON STABLE MEDICATION.

scientific article published in April 2018

F34. AUDITORY SENSORY GATING IN YOUNG ADOLESCENTS WITH EARLY-ONSET PSYCHOSIS: A COMPARISON WITH ADHD.

scientific article

Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology

scientific article published on 27 January 2016

Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender

scientific article published on 3 April 2006

Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade

scientific article published on 24 November 2015

Gating of the vertex somatosensory and auditory evoked potential P50 and the correlation to skin conductance orienting response in healthy men

article

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

scientific article published on 07 May 2019

Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits

scientific article published on 15 August 2012

Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence - A Danish nationwide study.

scientific article published on 8 March 2018

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers.

scientific article published on 6 February 2018

Heritability of Cerebral Blood Flow and the Correlation to Schizophrenia Spectrum Disorders: A Pseudo-continuous Arterial Spin Labeling Twin Study

scientific article published on 01 October 2019

Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register

scientific article

Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study

article by Christian Stefan Legind et al published 9 October 2018 in Neuropsychopharmacology

Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a [H]-spectroscopy twin study

article by Christian Stefan Legind et al published 9 October 2018 in Neuropsychopharmacology

Heritability of specific cognitive functions and associations with schizophrenia spectrum disorders using CANTAB: a nation-wide twin study

scientific article published on 11 August 2020

Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia

scientific article

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol

scientific article published on 30 April 2020

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

scientific article published on 01 January 2022

Impaired temporoparietal deactivation with working memory load in antipsychotic-naïve patients with first-episode schizophrenia

scientific article published on 6 March 2011

Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia

scientific article published on December 2012

In Memoriam: Arvid Carlsson-Pioneering Researcher and Nobel Laureate

article published in 2018

Increased psychophysiological parameters of attention in non-psychotic individuals with auditory verbal hallucinations

scientific article published on 21 May 2010

Information processing and attentional dysfunctions as vulnerability indicators in schizophrenia spectrum disorders

scientific article

Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms

scientific article published on 04 October 2020

Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.

scientific article

Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register

scientific article

Is oncogene activity involved in the alcohol withdrawal syndrome? ⬇️

scientific article published on October 1, 1991

Kindling: a model for the development of tardive dyskinesia?

scientific article published on 01 January 1988

Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?

scientific article

M80. Global Micro-Structural White Matter Alterations in the First-Episode Antipsychotic-Naive Schizophrenia Patients After 6 Weeks of Selective D2/3 Receptor Blockade.

scientific article

Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research

scientific article

Malignant neuroleptic syndrome or serotonergic syndrome

scientific article

Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness

scientific article

Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.

scientific article published on 25 October 2016

Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention

scientific article

Multimodal assessment of white matter microstructure in antipsychotic-naïve schizophrenia patients and confounding effects of recreational drug use

scientific article published on 06 January 2020

Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.

scientific article published on 27 March 2018

Negative Symptoms and Reward Disturbances in Schizophrenia Before and After Antipsychotic Monotherapy

scientific article published in November 2017

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients

scientific article published on 15 May 2014

Neural markers of negative symptom outcomes in distributed working memory brain activity of antipsychotic-naive schizophrenia patients

scientific article published on 20 November 2012

Neurobiological disturbances in schizophrenia

scientific article published in November 2008

Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo

scientific article published on 11 July 2016

Neurocognitive subgroups among newly diagnosed patients with schizophrenia spectrum or bipolar disorders: A hierarchical cluster analysis

scientific article published in 2023

No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia

scientific article published on 5 March 2017

Non-pharmacological modulation of cerebral white matter organization: A systematic review of non-psychiatric and psychiatric studies

scientific article published on 14 March 2018

Normal P50 Gating in Children with Autism, Yet Attenuated P50 Amplitude in the Asperger Subcategory

scientific article published on 20 January 2015

Normal p50 gating in unmedicated schizophrenia outpatients

scientific article published in December 2003

Norquetiapine and depressive symptoms in initially antipsychotic-naive first-episode schizophrenia

scientific article

O3.3. REWARD PROCESSING AS A VULNERABILITY INDICATOR FOR PSYCHOSIS: RESULTS FROM A TWIN STUDY.

scientific article published in April 2018

O4.2. HERITABILITY AND CORRELATION TO SCHIZOPHRENIA SPECTRUM DISORDER OF GLUTAMATE AND OTHER NEUROMETABOLITE LEVELS IN ANTERIOR CINGULATE AND LEFT THALAMUS: A REGISTER BASED MAGNETIC RESONANCE TWIN STUDY.

scientific article published in April 2018

O4.5. EXPLORING THE RELATIONSHIP BETWEEN SENSORY FILTERING AND COGNITION: RESULTS OF A LARGE COHORT OF ANTIPSYCHOTIC-NAïVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS

O4.6. HERITABILITY OF SPECIFIC COGNITIVE FUNCTIONS AND ASSOCIATIONS WITH SCHIZOPHRENIA SPECTRUM DISORDERS USING CANTAB: A NATION-WIDE TWIN STUDY

article by Cecilie Lemvigh et al published 9 April 2019 in Schizophrenia Bulletin

O5.6. REMISSION FROM ANTIPSYCHOTIC TREATMENT IN FIRST EPISODE PSYCHOSIS RELATED TO LONGITUDINAL CHANGES IN BRAIN GLUTAMATE LEVELS

O7.4. ASSOCIATIONS BETWEEN DOPAMINE SYNTHESIS CAPACITY, GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH FIRST EPISODE PSYCHOSIS

O8.1. ASSOCIATIONS BETWEEN REWARD ALTERATIONS AND THALAMIC GLUTAMATE LEVELS IN ANTIPSYCHOTIC-NAïVE FIRST-EPISODE PATIENTS WITH PSYCHOSES

Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use.

scientific article published on 15 April 2016

Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder.

scientific article published on 17 July 2017

P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment

scientific article

Patients with first-episode psychosis should not be scanned routinely

scientific article

Patterns of Cortical Structures and Cognition in Antipsychotic-Naïve Patients With First-Episode Schizophrenia: A Partial Least Squares Correlation Analysis

scientific article published on 25 September 2018

Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms.

scientific article published on 3 May 2017

Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning

scientific article published on 11 April 2020

Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function

scientific article published on 01 January 1993

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users

scientific article

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users

scholarly article by Lone Baandrup et al published 15 March 2018 in Cochrane Database of Systematic Reviews

Poster #10 MAGNETIC RESONANCE IMAGING CHARACTERIZATION OF EARLY POSTNATAL PHENCYCLIDINE TREATMENT AS A RAT MODEL OF SCHIZOPHRENIA

Prepulse inhibition in patients with Alzheimer's disease

scientific article

Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms

scientific article published on 12 August 2010

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: A randomised, placebo-controlled, blinded trial

scientific article published on 18 June 2015

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol ⬇️

scientific article

Psychiatric research ought to be central to long-term plans for psychiatry

scientific article

Relationship of frontal D(2/3) binding potentials to cognition: a study of antipsychotic-naive schizophrenia patients

scientific article published on 17 February 2012

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate

scientific article published on 01 August 2019

Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)

scientific article published on 07 June 2018

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

scientific article published on 24 April 2009

S12. A MACHINE LEARNING FRAMEWORK FOR ROBUST AND RELIABLE PREDICTION OF SHORT- AND LONG-TERM CLINICAL RESPONSE IN INITIALLY ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BASED ON MULTIMODAL NEUROPSYCHIATRIC DATA

scientific article

S15. HERITABILITY AND CORRELATION TO SCHIZOPHRENIA SPECTRUM DISORDERS OF CEREBRAL BLOOD FLOW MEASURED BY PSEUDO-CONTINUOUS ARTERIAL SPIN LABELING IN DANISH TWINS

S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS.

scientific article

S158. REWARD ALTERATIONS IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE-PSYCHOSIS PATIENTS BEFORE AND AFTER TREATMENT WITH A PARTIAL DOPAMINE AGONIST.

scientific article published in April 2018

S246. PSYCHOMETRIC PROPERTIES OF THE DANISH VERSION OF BNSS (BNSS-DA).

scientific article

S250. RELATION BETWEEN PSYCHOPATHOLOGY AND QUALITY OF LIFE IN SCHIZOPHRENIA PATIENTS BEFORE AND AFTER FIRST ANTIPSYCHOTIC TREATMENT.

scientific article

SA26. Increase in Set-Shifting Abilities After Illness Onset in Patients With Schizophrenia (a 7- to 16-Year Follow-Up Study).

scientific article

SA37. Cognition and White Matter Integrity in Antipsychotic-Naive First-Episode Schizophrenia Patients.

scientific article published on 20 March 2017

SA81. Glutamatergic and GABAergic Disturbances in Individuals at Ultra-High Risk of Psychosis: Implications for Clinical and Functional Outcome.

scientific article published on 20 March 2017

SA83. Brain Glutamate Levels and Antipsychotic Response in Schizophrenia.

scientific article

SA87. Cortical Thickness in Antipsychotic-Naive First-Episode Schizophrenia Patients and Associations With Caudate D2/3 Binding Potentials

scientific article published on 20 March 2017

SA90. Nonpharmacological Modulation of Cerebral White Matter Organization: A Systematic Review.

scientific article

SU18. GLP-1 Receptor Agonist Treatment in Schizophrenia Patients With Obesity

scientific article published on 20 March 2017

Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

scientific article published on January 2009

Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy

scientific article published on 26 April 2017

Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine

scientific article published on 16 July 2010

Serotonin 2A receptor antagonists for treatment of schizophrenia

scientific article published on 08 July 2011

Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine

scientific article published on 8 July 2010

Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade - An exploratory study

scientific article published on 08 February 2019

Source localization of sensory gating: a combined EEG and fMRI study in healthy volunteers

scientific article published on 23 November 2010

Stability of prepulse inhibition and habituation of the startle reflex in schizophrenia: a 6-year follow-up study of initially antipsychotic-naive, first-episode schizophrenia patients

scientific article published on 4 February 2011

Startle habituation, sensory, and sensorimotor gating in trauma-affected refugees with posttraumatic stress disorder

scientific article published on 17 May 2018

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study

article

Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome

scientific article

Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment

scientific article published on 6 January 2016

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients

scientific article published on 20 May 2020

Structural brain correlates of sensorimotor gating in antipsychotic-naive men with first-episode schizophrenia

scientific article

Supplementary data for a focused review and meta-analysis of 1H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states

scientific article published on 04 December 2019

Sustained weight loss after treatment with a glucagon-like peptide-1 receptor agonist in an obese patient with schizophrenia and type 2 diabetes

scientific article

Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study

scientific article published on 15 October 2020

Systemic oxidative DNA and RNA damage are not increased during early phases of psychosis: A case control study

scientific article published on 30 April 2016

T16. GLUTAMATERGIC CHANGES IN UHR.

scientific article published in April 2018

T248. PSYCHOPATHOLOGY IN F2X.X-UNAFFECTED CO-TWINS AS A VULNERABILITY INDICATOR OF PSYCHOSIS.

scientific article published in April 2018

T88. THE IMPACT OF AGE OF ONSET AND ILLNESS DURATION ON WHITE MATTER AND COGNITION TRAJECTORIES IN SCHIZOPHRENIA: A 7-YEAR FOLLOW-UP STUDY ACROSS MULTIPLE TIME-POINTS

T97. PATTERNS OF COGNITIVE FUNCTION ARE UNIQUELY ASSOCIATED WITH WHITE MATTER-MICROSTRUCTURE IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS

Testing a decades' old assumption: Are individuals with lower sensory gating indeed more easily distracted?

scientific article

The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics

scientific article published on 08 July 2016

The brain dopaminergic system. Pharmacological, behavioural and electrophysiological studies

scientific article published on February 1995

The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels

scientific article published on 13 February 2012

The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans

scientific article published on 25 January 2007

The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response

scientific article published on 14 February 2007

The effects of increased serotonergic activity on human sensory gating and its neural generators

scientific article published on 14 November 2007

The impact of schizophrenia and intelligence on the relationship between age and brain volume

The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.

scientific article

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics

scientific article

The promise of biological markers for treatment response in first-episode psychosis: a systematic review

scientific article

The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients

scientific article published on 15 January 2019

Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice

scientific article published on 01 February 2020

Transmitter dysfunction during the process of schizophrenia.

scientific article

Transmitter dysfunction in patients with schizophrenia. Significance for cognitive functioning and treatment

scientific article published in March 1999

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.

scientific article published on 08 January 2014

Treatment options for residual insomnia in schizophrenia

scientific article published on 26 October 2012

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

scientific article published on 16 September 2019

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

scientific article published on 6 December 2016

Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology

scientific article

Validation of the Danish version of the brief negative symptom scale

scientific article published on 13 August 2019

Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment

scientific article published on 18 December 2018

Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review

scientific article

White matter maturation during 12 months in individuals at ultra-high-risk for psychosis.

scientific article published on 16 November 2017

Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra-high risk for psychosis

scientific article published on 20 August 2019

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

scientific article

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio

scientific article published on April 2015

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care

scientific article published on 24 February 2017

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

scientific article published in January 2005

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia

scientific article published in January 2006

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

scientific article

[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region

scientific article published on 18 December 2006

[Cognitive deficits in schizophrenia and other psychotic disorders]

scientific article published on 01 November 2008

[White matter alterations in schizophrenia] ⬇️

scientific article published on 01 November 2014

Paulina is supported by:

About Paulina

Help